halothane has been researched along with Injury, Myocardial Reperfusion in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neither halothane nor sevoflurane protected the heart against the effects of acute and severe regional myocardial ischemia." | 7.70 | Anesthetic modulation of myocardial ischemia and reperfusion injury in pigs: comparison between halothane and sevoflurane. ( Coetzee, A; Coetzee, J; Conradie, S, 1999) |
| "Using canine coronary artery ligation/reperfusion and adrenaline arrhythmia models, we determined the effects of azimilide, a class III antiarrhythmic agent, E-1-[[(5-(4-chlorophenyl)-2-furanyl) methylene]-amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidi nedione dihydrochloride." | 7.70 | Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models. ( Chino, D; Hashimoto, K; Xue, Y; Yamada, C, 1999) |
| "Neither halothane nor sevoflurane protected the heart against the effects of acute and severe regional myocardial ischemia." | 3.70 | Anesthetic modulation of myocardial ischemia and reperfusion injury in pigs: comparison between halothane and sevoflurane. ( Coetzee, A; Coetzee, J; Conradie, S, 1999) |
| "Using canine coronary artery ligation/reperfusion and adrenaline arrhythmia models, we determined the effects of azimilide, a class III antiarrhythmic agent, E-1-[[(5-(4-chlorophenyl)-2-furanyl) methylene]-amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidi nedione dihydrochloride." | 3.70 | Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models. ( Chino, D; Hashimoto, K; Xue, Y; Yamada, C, 1999) |
| "The authors investigated the effects of halothane (HAL) and isoflurane (ISO) on cardiac depression produced by global hypoxia and the recovery of function following reoxygenation is isolated guinea pig hearts perfused with Krebs' solution at constant pressure." | 3.68 | Differential protective effects of halothane and isoflurane against hypoxic and reoxygenation injury in the isolated guinea pig heart. ( Bosnjak, ZJ; Kampine, JP; Marijic, J; Stowe, DF; Turner, LA, 1990) |
| "Sevoflurane was as effective as halothane in improving postcardioplegic functional performance." | 1.31 | Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: comparison with halothane. ( Coetzee, JF; Genade, S; le Roux, PJ; Lochner, A, 2000) |
| "Ca(2+) loading occurs during myocardial reperfusion injury." | 1.31 | Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(2+) loading in intact hearts. ( An, J; Novalija, E; Stowe, DF; Varadarajan, SG, 2002) |
| "Treatment with halothane during the early reperfusion period after myocardial ischaemia protected the myocardium against infarction in vivo, independent of the haemodynamic effect of halothane." | 1.30 | Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo. ( Barthel, H; Obal, D; Preckel, B; Schlack, W; Thämer, V, 1997) |
| "When halothane was added on reoxygenation, Ca2+ oscillations were markedly reduced (4+/-2 per minute, P<." | 1.30 | Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. ( Balser, C; Ladilov, YV; Piper, HM; Schlack, W; Siegmund, B, 1997) |
| "Halothane has been shown to be a powerful myocardial protectant during normothermic cardioplegic arrest and subsequent reperfusion." | 1.30 | Postcardioplegic myocardial recovery: effects of halothane, nifedipine, HOE 694, and quinacrine. ( Genade, S; Lochner, A; Theron, S; Trollip, G; Tromp, E, 1998) |
| "Halothane (1." | 1.29 | Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion. ( Coetzee, AR; Genade, S; Harper, IS; Lochner, A; Salie, R, 1994) |
| "When halothane was administered at reoxygenation, CK release was reduced to 10." | 1.29 | Effect of halothane on myocardial reoxygenation injury in the isolated rat heart. ( Hollmann, M; Schlack, W; Stunneck, J; Thämer, V, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 14 (77.78) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodriguez-Sinovas, A | 1 |
| García-Dorado, D | 1 |
| Ruiz-Meana, M | 1 |
| Soler-Soler, J | 1 |
| Lochner, A | 3 |
| Harper, IS | 1 |
| Salie, R | 1 |
| Genade, S | 3 |
| Coetzee, AR | 1 |
| Louvier, N | 1 |
| Lançon, JP | 1 |
| Marijic, J | 2 |
| Buljubasic, N | 1 |
| Coetzee, A | 2 |
| Moolman, J | 1 |
| Schlack, W | 4 |
| Hollmann, M | 1 |
| Stunneck, J | 1 |
| Thämer, V | 3 |
| Preckel, B | 2 |
| Barthel, H | 1 |
| Obal, D | 1 |
| Siegmund, B | 1 |
| Ladilov, YV | 1 |
| Balser, C | 1 |
| Piper, HM | 1 |
| Tromp, E | 1 |
| Theron, S | 1 |
| Trollip, G | 1 |
| Honda, O | 1 |
| Inoue, K | 1 |
| Takaba, T | 1 |
| Conradie, S | 1 |
| Coetzee, J | 1 |
| Xue, Y | 1 |
| Yamada, C | 1 |
| Chino, D | 1 |
| Hashimoto, K | 1 |
| Coetzee, JF | 1 |
| le Roux, PJ | 1 |
| Varadarajan, SG | 1 |
| An, J | 1 |
| Novalija, E | 1 |
| Stowe, DF | 2 |
| Turner, LA | 1 |
| Kampine, JP | 2 |
| Bosnjak, ZJ | 1 |
| Belo, SE | 1 |
| Mazer, CD | 1 |
| Warltier, DC | 1 |
| al-Wathiqui, MH | 1 |
| Schmeling, WT | 1 |
1 review available for halothane and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
[Do halogenated anesthetics protect from ischemic and reperfusion myocardial injuries?].
Topics: Animals; Calcium Channels; Cats; Dogs; Enflurane; Free Radicals; Halothane; Heart; Isoflurane; Myoca | 1994 |
17 other studies available for halothane and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Enhanced effect of gap junction uncouplers on macroscopic electrical properties of reperfused myocardium.
Topics: Action Potentials; Animals; Dose-Response Relationship, Drug; Gap Junctions; Halothane; Heptanol; Ma | 2004 |
Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion.
Topics: Animals; Body Temperature; Calcium; Halothane; Heart Arrest, Induced; Hemodynamics; In Vitro Techniq | 1994 |
Volatile anesthetics and myocardial stunning.
Topics: Animals; Halothane; Isoflurane; Myocardial Reperfusion Injury; Rabbits | 1993 |
Halothane and the reperfusion injury in the intact animal model.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Dose-Response Relationship, Drug; Halothane; | 1993 |
Effect of halothane on myocardial reoxygenation injury in the isolated rat heart.
Topics: Anesthetics, Inhalation; Animals; Creatine Kinase; Halothane; Male; Myocardial Contraction; Myocardi | 1996 |
Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo.
Topics: Anesthetics, Inhalation; Animals; Coronary Disease; Dose-Response Relationship, Drug; Female; Haloth | 1997 |
Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture.
Topics: Anesthetics, Inhalation; Animals; Calcium; Cytosol; Halothane; Heart; Hydrogen-Ion Concentration; Hy | 1997 |
Postcardioplegic myocardial recovery: effects of halothane, nifedipine, HOE 694, and quinacrine.
Topics: Analysis of Variance; Anesthetics, Inhalation; Animals; Calcium Channel Blockers; Dose-Response Rela | 1998 |
Enflurane and isoflurane, but not halothane, protect against myocardial reperfusion injury after cardioplegic arrest with HTK solution in the isolated rat heart.
Topics: Anesthetics, Inhalation; Animals; Cardioplegic Solutions; Creatine Kinase; Enflurane; Glucose; Halot | 1998 |
[Protective effects of halothane on ischemic reperfusion injury on rat perfused hearts].
Topics: Anesthetics, Inhalation; Animals; Coronary Circulation; Halothane; Heart Rate; In Vitro Techniques; | 1998 |
Anesthetic modulation of myocardial ischemia and reperfusion injury in pigs: comparison between halothane and sevoflurane.
Topics: Adjuvants, Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Fentanyl; Halotha | 1999 |
Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models.
Topics: Anesthetics; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Epinephrine; Female; Halot | 1999 |
Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: comparison with halothane.
Topics: Adenine Nucleotides; Anesthetics, Inhalation; Animals; Glyburide; Halothane; Heart Arrest, Induced; | 2000 |
Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(2+) loading in intact hearts.
Topics: Anesthetics, Inhalation; Animals; Calcium; Guinea Pigs; Halothane; In Vitro Techniques; Ischemic Pre | 2002 |
Differential protective effects of halothane and isoflurane against hypoxic and reoxygenation injury in the isolated guinea pig heart.
Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Node; Guinea Pigs; Halothane; Heart; Heart Rate; Hyp | 1990 |
Effect of halothane and isoflurane on postischemic "stunned" myocardium in the dog.
Topics: Animals; Dogs; Halothane; Hemodynamics; Isoflurane; Myocardial Contraction; Myocardial Reperfusion I | 1990 |
Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane.
Topics: Anesthesia; Animals; Consciousness; Coronary Disease; Dogs; Female; Halothane; Isoflurane; Male; Myo | 1988 |